HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $329,734 | -11.2% | 320,130 | 0.0% | 0.04% | -15.2% |
Q2 2023 | $371,351 | +102.2% | 320,130 | +163.2% | 0.05% | +84.0% |
Q1 2023 | $183,661 | -47.8% | 121,630 | -13.6% | 0.02% | -51.0% |
Q4 2022 | $352,125 | -40.7% | 140,850 | 0.0% | 0.05% | -60.5% |
Q3 2022 | $594,000 | +312.5% | 140,850 | +173.5% | 0.13% | +377.8% |
Q2 2022 | $144,000 | -51.2% | 51,500 | 0.0% | 0.03% | -30.8% |
Q1 2022 | $295,000 | – | 51,500 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $783 | 100.00% |
Velan Capital Investment Management LP | 6,986,744 | $7,196,346 | 5.80% |
Tejara Capital Ltd | 2,109,681 | $2,172,971 | 1.23% |
JW Asset Management, LLC | 2,407,418 | $2,479,641 | 1.07% |
Rubric Capital Management LP | 26,713,503 | $27,514,908 | 1.03% |
GREAT POINT PARTNERS LLC | 4,737,368 | $4,879,489 | 0.89% |
Orchard Capital Management, LLC | 2,142,823 | $2,207,108 | 0.82% |
Clearline Capital LP | 6,149,842 | $6,334,338 | 0.54% |
CM Management, LLC | 450,000 | $463,500 | 0.49% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 327,450 | $337,274 | 0.48% |